| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Elizabeth M. Brunt | Q110296299 |
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Liver fibrosis in overweight patients | Q28145482 | ||
| One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study | Q28246121 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Nonalcoholic fatty liver disease | Q74119103 | ||
| Alcoholic and nonalcoholic steatohepatitis | Q74475086 | ||
| Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology | Q74577755 | ||
| Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity | Q29614914 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease | Q30303621 | ||
| Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions | Q33731663 | ||
| Molecular virology of hepatitis B virus | Q33979065 | ||
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association | Q34112671 | ||
| Chronic hepatitis C and superimposed nonalcoholic fatty liver disease | Q34308953 | ||
| Update on nonalcoholic fatty liver disease | Q34548921 | ||
| Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? | Q34795935 | ||
| Pathogenesis of steatohepatitis | Q34983506 | ||
| Interaction of non-alcoholic fatty liver disease with other liver diseases. | Q34983530 | ||
| Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease | Q35044979 | ||
| Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? | Q35050963 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial | Q35681885 | ||
| Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens | Q35877265 | ||
| Steatosis: co-factor in other liver diseases. | Q36165987 | ||
| The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q36218262 | ||
| Insulin resistance: a metabolic pathway to chronic liver disease | Q36297331 | ||
| Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease | Q38416523 | ||
| Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens | Q42990788 | ||
| Nonalcoholic steatohepatitis: An expanded clinical entity | Q43036189 | ||
| Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis | Q43542965 | ||
| Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease | Q43660617 | ||
| Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese | Q43662697 | ||
| NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome | Q43875846 | ||
| In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases | Q44036833 | ||
| Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States | Q44269254 | ||
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
| Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values | Q44458156 | ||
| Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone | Q44598595 | ||
| A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis | Q44749300 | ||
| Nonalcoholic fatty liver disease in patients with type 2 diabetes | Q44797472 | ||
| Novel endothelial cell markers in hepatocellular carcinoma | Q46161399 | ||
| Ethnic differences in the prevalence of cryptogenic cirrhosis | Q46186734 | ||
| Histopathology of pediatric nonalcoholic fatty liver disease. | Q46735998 | ||
| Beyond insulin resistance in NASH: TNF-alpha or adiponectin? | Q47236730 | ||
| Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss | Q47417361 | ||
| Chronic hepatitis. An update on terminology and reporting. | Q53635198 | ||
| Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | Q55033443 | ||
| Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
| An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities | Q73234094 | ||
| Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver | Q74103273 | ||
| P921 | main subject | fatty liver disease | Q6058862 |
| P304 | page(s) | S40-8 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Pathology of fatty liver disease | |
| P478 | volume | 20 Suppl 1 |
| Q36134426 | A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD |
| Q42824021 | A protective role for CD154 in hepatic steatosis in mice |
| Q46141813 | Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice |
| Q84988668 | Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease |
| Q47703923 | Antigenotoxic and Antioxidant Activity of Methanol Stem Bark Extract of Napoleona Vogelii Hook & Planch (Lecythidaceae) In Cyclophosphamide-Induced Genotoxicity. |
| Q50027558 | Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy |
| Q46769638 | Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers |
| Q35847172 | Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis |
| Q35602513 | Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease |
| Q47141193 | Automated quantification of steatosis: agreement with stereological point counting |
| Q97524395 | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases |
| Q83259351 | Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease |
| Q91927091 | Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound |
| Q34152582 | Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties |
| Q54260249 | Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease. |
| Q64114918 | Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression |
| Q39485275 | Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development |
| Q64880524 | Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients. |
| Q60513161 | Effects of a Diet Rich in n-3 Polyunsaturated Fatty Acids on Hepatic Lipogenesis and Beta-Oxidation in Mice |
| Q42219793 | Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection |
| Q38607500 | Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin |
| Q36194904 | Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins |
| Q35148692 | Evaluation of portal venous velocity with Doppler ultrasound in patients with nonalcoholic fatty liver disease |
| Q36367014 | Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment. |
| Q38689700 | Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools |
| Q61445386 | Focal hypersteatosis: a pseudolesion in patients with liver steatosis |
| Q58084446 | Focused scores enable reliable discrimination of small differences in steatosis |
| Q42657454 | HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD. |
| Q51533916 | Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes. |
| Q41506217 | Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience |
| Q35602046 | Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet |
| Q62089902 | High Sucrose Intake Ameliorates the Accumulation of Hepatic Triacylglycerol Promoted by Restraint Stress in Young Rats |
| Q37858449 | Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease |
| Q43196846 | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. |
| Q39045054 | Imaging patterns and focal lesions in fatty liver: a pictorial review |
| Q53358958 | In vivo (1)H-MRS hepatic lipid profiling in nonalcoholic fatty liver disease: an animal study at 9.4 T. |
| Q39725341 | Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. |
| Q92121725 | In Vivo RNAi-Mediated eIF3m Knockdown Affects Ribosome Biogenesis and Transcription but Has Limited Impact on mRNA-Specific Translation |
| Q33593809 | Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells |
| Q92267363 | Liver Transplantation Using Steatotic Grafts |
| Q37976890 | Liver X receptors bridge hepatic lipid metabolism and inflammation |
| Q43208286 | Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. |
| Q90288192 | Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators |
| Q36101050 | Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). |
| Q37078311 | Non alcoholic fatty liver disease and metabolic syndrome. |
| Q37417603 | Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study |
| Q82707785 | Nonsynonymous variants and fatty liver disease |
| Q90628958 | Nutrigenomic effect of conjugated linoleic acid on growth and meat quality indices of growing rabbit |
| Q33918850 | Obesity, overweight and liver disease in the Midspan prospective cohort studies. |
| Q37807779 | Pediatric nonalcoholic fatty liver disease: a comprehensive review. |
| Q41927137 | Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention |
| Q41059980 | Practical management of the increasing burden of non-alcoholic fatty liver disease |
| Q52730229 | Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. |
| Q34009236 | Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver |
| Q35012726 | Role of lipid rafts in liver health and disease |
| Q39682920 | Serum amyloid A immunohistochemical staining patterns in hepatitis |
| Q43055877 | Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease |
| Q92767348 | Spatial heterogeneity in the mammalian liver |
| Q24201595 | Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis |
| Q34404381 | Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring |
| Q39461923 | Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses. |
| Q64078618 | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose |
| Q88575808 | The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury |
| Q39542765 | The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. |
| Q40414261 | The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis. |
| Q35149005 | The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication |
| Q37205362 | Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States |
| Q46277127 | Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis |
| Q83176738 | [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines] |
Search more.